Please try another search
Samsung Biologics Co.,Ltd. engages in the contract manufacturing organization (CMO) business for biopharmaceuticals products. The company operates in two segments, Contract Development and Manufacturing Organization Business, and Biopharmaceutical Development and Commercialization Business. It is involved in the provision of CDO services, including cell line development, upstream and downstream processes, and analytical methods and formulations. The company also offers aseptic filling, lyophilization, finishing, storage and shipping, and support services; and quality assurance and control, as well as biosafety and analytical testing services. In addition, it engages in the development and commercialization of biosimilar drugs; and manufactures mammalian cell-based antibody drugs. The company was founded in 2011 and is headquartered in Incheon, South Korea.
Name | Age | Since | Title |
---|---|---|---|
Changwoo Lee | 53 | - | Independent Director |
Kyunghee Kim | 63 | 2020 | Independent Outside Director |
Geunnyeong Heo | 67 | 2019 | Independent Director |
Dogeol Ahn | - | 2023 | Independent Director |
Jaewan Bahk | 68 | 2022 | Independent Director |
Dong-Joong Kim | 58 | 2014 | CFO, Executive VP, MD & Director |
John Chongbo Rim | 62 | 2019 | CEO, President & Chairman of Board |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review